ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

May 27, 2011

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

Peer Review Study Team Plans Hearing

December 12, 1975

DeVita Says Payline Compression Leading to More Decisions By Staff On Funding

June 28, 1985

How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director

November 19, 1999

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001